Clinical Trials in Amsterdam, North Holland
2 recruiting
Showing 1–9 of 9 trials
Recruiting
Phase 3
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Mirati Therapeutics Inc.630 enrolled337 locationsNCT06875310
Recruiting
Phase 3
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Breast Neoplasms
Merck Sharp & Dohme LLC1,200 enrolled257 locationsNCT06312176
Recruiting
Phase 3
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Breast CancerMetastatic Breast CancerAdvanced Breast Cancer+1 more
Olema Pharmaceuticals, Inc.510 enrolled233 locationsNCT06016738
Recruiting
Phase 2Phase 3
Contrast-enhanced Ultrasound for Sentinel Node Detection
Breast CancerMelanomaHead & Neck Cancer
The Netherlands Cancer Institute91 enrolled1 locationNCT07310758
Recruiting
Not Applicable
Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients
Breast Cancer
The Netherlands Cancer Institute100 enrolled1 locationNCT06273800
Recruiting
Not Applicable
Assessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to Immunotherapy Treatment Response in Non-Small Cell Lung Cancer
NSCLC
Amsterdam UMC, location VUmc34 enrolled1 locationNCT06457789
Recruiting
Not Applicable
DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy
Breast Cancer
The Netherlands Cancer Institute595 enrolled1 locationNCT05416164
Recruiting
Phase 2
NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial
Metastatic Breast Cancer
The Netherlands Cancer Institute60 enrolled1 locationNCT06342037
Recruiting
Not Applicable
Dynamic and Test-retest Whole Body [18F]FES PET Imaging in Patients With Metastatic ER+ Breast Cancer
Breast Cancer
Amsterdam UMC, location VUmc15 enrolled1 locationNCT05088785